| 000 | 01719 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517142641.0 | ||
| 264 | 0 | _c20180426 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1938-0682 | ||
| 024 | 7 |
_a10.1016/j.clgc.2017.01.024 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBuisan, Oscar | |
| 245 | 0 | 0 |
_aRole of Inflammation in the Perioperative Management of Urothelial Bladder Cancer With Squamous-Cell Features: Impact of Neutrophil-to-Lymphocyte Ratio on Outcomes and Response to Neoadjuvant Chemotherapy. _h[electronic resource] |
| 260 |
_bClinical genitourinary cancer _c08 2017 |
||
| 300 |
_ae697-e706 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdrug therapy |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aLymphocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aNeutrophils |
| 650 | 0 | 4 | _aPerioperative Period |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aROC Curve |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
| 700 | 1 | _aOrsola, Anna | |
| 700 | 1 | _aOliveira, Mario | |
| 700 | 1 | _aMartinez, Roberto | |
| 700 | 1 | _aEtxaniz, Olatz | |
| 700 | 1 | _aAreal, Joan | |
| 700 | 1 | _aIbarz, Luis | |
| 773 | 0 |
_tClinical genitourinary cancer _gvol. 15 _gno. 4 _gp. e697-e706 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clgc.2017.01.024 _zAvailable from publisher's website |
| 999 |
_c26950141 _d26950141 |
||